chrisvoncsefalvay/vaers-outcomes huggingface dataset:
difficulty swallowing; spots on throat; blood in urine; allergic reaction to the vaccine; all over rash; fatigue; blisters that looks like shingles; shingles/looks like shingles; This case was reported by a pharmacist via call center representative and described the occurrence of allergy to vaccine in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number MP42R, expiry date 19th September 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 4th June 2019 without incidence).   On 6th August 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 8th August 2019, 2 days after receiving Shingrix, the patient experienced allergy to vaccine, generalized rash and fatigue. On 11th August 2019, the patient experienced hematuria. In August 2019, the patient experienced vesicular rash and blister. On 18th August 2019, the patient experienced swallowing difficult and throat lesion. The patient was treated with prednisone. On an unknown date, the outcome of the allergy to vaccine, vesicular rash, fatigue, blister, swallowing difficult and throat lesion were not recovered/not resolved and the outcome of the generalized rash was recovering/resolving and the outcome of the hematuria was unknown.   It was unknown if the reporter considered the allergy to vaccine, vesicular rash, generalized rash, fatigue, blister, hematuria, swallowing difficult and throat lesion to be related to Shingrix.  Additional information was provided as follows: The reporter was the son of the patient. The patient did not have history of Shingles. The patient received Shingrix in left deltoid in another pharmacy. The patient experienced an all over rash and fatigue.   On 9th August 2019, she saw her physician.  The patient's labs were drawn, which showed a normal CBC but she did have blood in her urine. The reporter thought, the patient might had a viral infection.  On 11th August 2019, the patient was seen at urgent care and given a prednisone dose pack and told it was an allergic reaction to the vaccine. Somewhere in there, the patient also developed blisters on both arms which looked like shingles, as per the reporter. These Blisters were in clusters and had gotten worse. On the day before the reporting date, the patient had difficulty swallowing and spots on her throat, so she went back to her primary care physician, who sent her to the local emergency room.   The rash appeared a little better, the fatigue was the same and the blisters were worse. At the time of reporting, the reporter did not know if the patient would be admitted or not. The reporter consented to follow up.
Information has been received from a medical assistant concerning an about 10 year old female who on 02-SEP-2009 was vaccinated with a dose of GARDASIL, influenza virus vaccine (unspecified), VARIVAX (MSD) and MENACTRA, all at the same time. The nurse reported that the patient experienced lightheadedness or dizziness but she did not pass out after receiving all the 4 vaccinations. At the time of the report, it was reported that the patient recovered "a few weeks ago". The patient sought unspecified medical attention. Follow up information was received from the medical assistant who stated that there really was no adverse experience, that they decided patient also had laboratories done and that first time just got a little nausea. No further information is available.
Extreme pain in arm/should (same side as flu shot was given), rash.  Turned out to be shingles and when I looked it up there are many people saying the same thing.
1st Dose of Covid-19 Covid-19 Moderna/ 013M20A 02/03/2021  2nd Dose of Covid-19 Covid-19 Moderna/012A21A 03/03/2021  Since having the second vaccine I have issues with running noticeably short of breath.  On April 6th I was admitted because my hemoglobin had drop to 6.9. They had to give me a blood transfusion. They also ran a scope on my upper GI, and I swallowed a camera to see if there was any blood being loss in my GI tract. None was found.  The next test was to get a biopsy of my bone marrow. The results showed that the erythropoietin anti-bodies were destroying my red blood cell. My hemoglobin is still at 7.3 and the shortness of breath is still having it?s toll on me.  I is my believe that the Moderna Covid-19 maybe the cause of my health issues, that I am experiencing. My breathing issues stating after getting the vaccine. I really think this information should be noted in case others may have the same problem. Please know that I had no breathing issue before getting the vaccine.
Per hospital reporting system vaccine give to wrong patient "dr gave verbal order to give flu vaccine and pneumovax 23, walked into the room and stated that had her shots ready and gave the pneumovax first , after receiving vaccine she stated that she already had her flu vaccine and that she had the both pneumonia vaccine 3 and 4 years ago . the patient was correct and the vaccine were to go to another roomed patient . pt stated that she was waiting to have ears cleaned."
Chills, aches, and extreme fatigue. Rotated ibuprofen and tylenol for 24 hours until symptoms subsided
Developed a migraine headache on September 13 in the early morning. Pain localized on left side of head. Nausea, light sensitivity, cold extremities experienced. Symptoms lasted for 48 hours. My last migraine was more than 15 years ago and none ever lasted more than one day.
Pt had remote H/O ITP treated with steroids once in the past (>25 years ago.) Presented in April with Severe/refractory ITP and has been hospitalized for over 2 weeks. May need splenectomy this weekend as plt count still only 5K after steroids, IVIG, Romiplostim (max dose (10mcg/kg)).
When I received my shot there must have been air inside the needle because myself and the nurse who gave me the shot heard a pop noise. The male nurse even looked at the needle. After the 1st 24 hours after shot i had a mild fever and tired. After 2nd day after receiving vaccine my arm  was very swollen and red.  Its been almost 2 weeks and  i still have a small knot at the injection site.  I occasionally feel a sharp pain in my arm from time to time.
potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose; potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose; This is a spontaneous report from a contactable Pharmacist. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The pharmacist was questioning as to guidelines to the potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose. The outcome of the event was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: The reported potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
I had swelling in the armpit of the vaccination arm. The swelling was so severe it was visible from the outside. When I hold up both arms, it looks like I have a little pillow in my left armpit. There is no redness. I have treated it with ibuprofen and warm compresses.
Squamous cell cancer on left face. Mohs procedure on 3/2021. Follow up on may1 st
Pt had physical exam and received vaxs. His left thigh were the pneumococcal vax was received was erythematous, swollen, without induration 2 days post vax (6x7 cm in size). Pt also had no fever. Right thigh was nml.
Patient received the monovalent Pfizer COVID-19 vaccine as their booster dose instead of the intended bivalent Pfizer COvID-19 vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 since 08-Jan-2021.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell). At the time of the report, PARANASAL SINUS DISCOMFORT (sinus pressure behined her eyes), AGEUSIA (loss of taste and smell) and ANOSMIA (loss of taste and smell) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No adverse event; Dose 1 on 01-Mar-2021, dose 2 on 22-Mar-2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 01-Mar-2021, dose 2 on 22-Mar-2021) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No acute illness at the time of vaccination and one month prior.  Concurrent medical conditions included Hyperlipidemia, Chronic kidney disease, Hypofunction testicle and Allergy to antibiotic (Clindamycin).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 01-Mar-2021, dose 2 on 22-Mar-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 01-Mar-2021, dose 2 on 22-Mar-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 on 01-Mar-2021, dose 2 on 22-Mar-2021).    Patient had first dose of Flu vaccine intramuscular, left deltoid with lot number 9249L. Concomitant medication list was not provided. Treatment information was not provided.   This case was linked to MOD-2022-651873 (Patient Link).
Severe muscle aches (entire body - especially lower back), headaches, fever/chills for 2 days, started period 5 days early.
10/18/17 -3:30PM - Headache - took Tylenol. 10/18/17 -5:00PM - Beginning of strong migraine - went home and to sleep. 10/19/17 -12:30PM - Took off sick from work after 15Hrs+ of sleep in a migraine state - Took Aleve + Tylenol. Nauseous with some hot flashes at times and a bit of a fever. Went through the swets twice. Had the shivers as well. 10/20/17 - 8:00AM - Went back to work. Though head still wasn't great leaning over or sneezing really hurts my head. 10/21-22/17  Not feeling all that great still. Very much physical motion makes me nauseous and head hurts. Sneezing hurts badly. 10/23/17 - 5:30AM - Wake up with a small migraine. Took migraine over the counter medicine. Nauseous while still being very physical or hitting bumps in the road. Neck still feels tense and not much is needed to cause head to hurt.
The pt experienced achiness, stomach pain, all over aches has heart problems, mild temp, pounding headaches. No diarrhea or vomiting. Went to the ER and was checked for heart problems. The pt has had a previous heart attack and thought was flu. The pt is on Cefcil, Flonase for 7 days.
Within 15-minutes of vaccination, the patient reported dizziness and feeling lightheaded. EMS managed patient's care on-site. Patient was hypertensive (178/96), SPO2 96%, and HR 90bpm. EKG was unremarkable. FSBG was 137 mg/dl. During EMS evaluation, patient stated they were feeling better and refused transport to hospital.
Dizziness started the afternoon the day after the vaccine.  Has persisted 9 days now and continues.
Left shoulder blade pain that spread to injection site. A rash appeared, + blisters came on the arm. Called doctor, they may send something later for patient.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. The patients' medical history, current conditions and concomitant medications were not reported. On unknown dates since July 2015, the patients were inadvertently vaccinated with improperly stored doses of VAQTA (dose, route and lot number were not provided). No adverse reactions were reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a MA in a doctor's office concerning a 34 month old male with no known allergies or adverse reactions who on 15-SEP-2003 was vaccinated subcutaneously with MMR II (lot number 645629/0390N). Concomitant suspect therapy included Varivax. It was reported that the child was given MMR II and since had not been right. The MA reported that the pt had not been diagnosed but "they suspect autism." At the time of this report, the outcome of the event was unknown. Upon internal review, autism was considered to be an other important medical event (OMIC). Additional information has been requested.
He experienced arm and neck pain limiting movement, which made him unable to play golf on Thursday. I talked to him on 7-31-23 and he was better. Today on the phone it was not completely gone but much better. He texted his doctor and he said he believed it was a local reaction and to take Tylenol or Motrin and apply a warm compress.
Kinrix vaccine was administered to a 7 year old patient. Kinrix is licensed through the age of 6 years. Patient has not reported any adverse reactions or events after vaccine administration.
a spike in blood pressure; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at an unknown dose, single dose for COVID-19 immunization. The patient's medical and concomitant medications were not reported. On an unspecified date, the patient experienced a spike in blood pressure after getting the COVID vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
5 minutes after booster injection, I noticed the injection site was starting to itch.  I looked at it and it was red.  I waited 5 more minutes and I felt more of my arm and chest starting to itch.  My upper arms, armpit and chest was red. I notified the RN and was taken to lay down.  I felt very hot.  BP was elevated.  Neck and head started to itch.  At about 1245 Benadryl was given orally and I was wheeled to the Emergency department.  BP 220/110.  I felt dizzy and back and upper legs also starting to itch.  Oral steroids given and also prescribed for the next 4 days.
2/17/22 pt sent to hospital from another facility after CVA; c/o abdominal pain and hypokalemia; pt bedbound; watery stools; dehydrated; ileus; found to be positive for COVID; given Decadron; started on O2 supplementation; developed Bacteremia from Staphylococcus aureus; respiratory status worsened requiring BiPAP; no improvement; pt was DNR; pt passed away in the hospital
This report was identified from a line listing on request by the Company from the FDA under the Freedom of Information Act. A 15 year old female patient with no medical history, was vaccinated IM in the left arm, on 16-MAR-2007, with the second dose of Gardasil (Lot #656051/0244U). On 27-MAR-2007 the patient experienced severe myalgias that progressed over 2 weeks until the patient was unable to sit up or walk. On 04-APR-2007, the patient developed a fever and within one hour of onset, became hypotensive and developed a flushing rash: she was admitted to the pediatric intensive care unit (PICU). The patient experienced the events of abasia, diarrhea, flushing , hypokinesia, hypotension, hypotension, inflammation, myalgia, nausea, pharyngolaryngeal pain, pyrexia and rash. Treatment included pressors (unspecified) and dopamine. As of 06-APR-2007, no source had been identified (the source of infection may have been an inflammed area on the back of the patient's earlobe at an earring hole site), and the patient was improving. The listing indicated that one or more of the events required a visit to the emergency room, resulted in hospitalization, was considered to be life threatening. No further information is available. The original reporting source was not identified. The records of testing prior to release of the lot in question, have been rechecked and found to be satisfactory. The lot complies with the standards and was released. 04-Apr-2007 DA Streptococcus oralis culture negative, 04-Apr-2007 DA blood negative, 04-Apr-2007 DA chest X-ray normal, 04-APR-2007 DA diagnostic hematology blood test negative, 04-APR-2007 DA erythrocyte sedimentation rate 36 (units not provided), 04-Apr-2007 DA serum C-reaction protein test 8.3 (units not provided), 04-Apr-2007 DA serum antistreptolysin O antigen test negative, 04-Apr-2007 DA urine culture negative, 04-Apr-2007 DA white blood cell count elevated.
sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-054691 (Patient Link).
Chills, Shivering, Nausea, Headache, Muscle Ache, Fatigue, Earache, chest pain The chills, shivering, ear ache and chest pain lasted 12 hours. Nausea, headache, muscle ache and fatigue lasted 24 hours. Treatment was ibuprofen and Naproxen.
19cm Red Swollen area on Left Arm , fever >101.1 Arthus reaction from Tdap vaccination
Headache; Facial redness; Hives; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 13:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included lumbar radiculopathy and known allergies to sulfa and food- onions. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), oxybutynin (MANUFACTURER UNKNOWN), biotin (MANUFACTURER UNKNOWN), naproxen sodium (NAPROXEN) and ammonium chloride, diphenhydramine hydrochloride, menthol, sodium citrate (BENADRYL); all for unknown indications, since unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 13:15, the patient experienced headache, facial redness, hives and body aches. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken for the reported events. The clinical outcome of the event headache, facial redness, hives and body aches was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
I got my 2nd Moderna shot on 4/22/2021 and had unexplained spotting on 5/17/2021, about a week before I would later start my period.  I saw my gynecologist and had a transvaginal ultrasound done and did not find anything concerning.  My gynecologist believes menstrual irregularities is the result of my body falling ill after the 2nd Moderna shot. About 12 hours after the 2nd Moderna shot, I developed chills and a fever of 102.7 F.  The fever lasted approx. 24 hours from onset.  I took a Tylenol which helped (otherwise, the fever and chills could have been worse/longer).  I also had headaches on and off until approx. 3rd day after the shot.  The injection site was also swollen, blue/purple, and itchy (with symptoms peaking about 5 days after the shot).
Pt stated that on the evening of receiving her flu & pneumococcal vaccination that her right arm  (pneumococal) because swollen from elbow to shoulder. This swelling was painful and lasted 3 days.
Continuous crying from time of vax; Pt was seen in ER 24 hrs later because of irritability & vomiting x 1; no fever PE neg; crying persisted through 4MAR92; Seemed better 5MAR92; again fretful 6MAR92; repeat PE again neg; no fever or vomit
pt recvd vax 8JUL94 mom states pt started w/fever 101 same day; On 10JUL94 pt started w/diarrhea & vomiting & body rash; pt taken to MD
Information has been received from a physician concerning a 6 month old female who on 27-AUG-2007 was vaccinated with her third dose of Rotateq. On 04-SEP-2007 the patient had been admitted to a local hospital for a suspected intussusception. On 05-SEP-2007 was sent to a hospital. Medical attention was sought via hospital admission. There was no product quality complaint. No further information is available.  9/18/007 Received patient demographics from CDC. 9/18/07 Received ER medical records which reveal patient experienced abdominal pain, vomiting, bloody diarrahea, lethargy w/palpable mass in left mid abdomen.  Had additional bloody diarrhea in ER.  Transferred to higher level of care. ER Dx: Intussusception.  9/27/07 Linked w/291340. 10/19/07 Reviewed vaccination record from pcp.  VAERS database updated w/same.  Records faxed to CDC. 11/2/07 Received hospital medical records which reveal patient experienced bloody stools & fever.  Admitted 9/5-9/12/2007.  IS not reducible by BE in ER & was taken to surgery for laparoscopic reduction & exp laparotomy.  Ileocecectomy performed to remove ischemic segment of cecum.  ID consult done. Did well postoperatively & d/c to home FINAL DX: Intussusception, surgically reduced.  Records faxed to CDC.